Dr. Fred Beasley provides an overview of study design, criteria for defining your study aim and expert advice for selecting the ideal rodent model for your preclinical obesity research.
During this presentation, Dr. Fred Beasley will give a broad-level overview of the factors to consider when deciding on an appropriate preclinical rodent model for studying obesity and its treatments. It will feature an overview of trends in obesity and associated illnesses, and the role of pharmacological intervention. Dr. Beasley will discuss criteria for establishing a study’s aims and review commonly used rodent models obesity, addressing both genetically inherited and diet-induced animal models. The webinar will conclude with additional considerations for improving your study design.
Key Topics Include:
- An introduction to the role of pharmacological intervention in treating obesity
- A guide to establishing study aims for obesity research
- An overview of commonly used rodent obesity models (diet and genetic)
- Additional considerations for obesity research study design
Key methods reviewed will include…
Pharmacotherapy, diet induced obesity, Western-style diet, monogenic obese rodents, polygenic obese rodents, NAFLD activity score
Additional Content From CrownBio
OBESITY SERIES 2020: Camilla Schéele & Christian Wolfrum discuss the physiology of brown adipose tissue and share late-breaking research on the role of BAT in whole body metabolic regulation.
Dr. Thomas Scullion discusses how to leverage NHP exploratory toxicology studies to guide and explore lead optimization, dosing paradigms, and future GLP studies.
Fred Beasley, PhD discusses how to select the most appropriate animal models for your preclinical obesity studies.
A Comprehensive How-To Demonstration of Higher Throughput Excitation-Contraction Coupling Investigations
Join Michiel Helmes and Diederik Kuster as they demonstrate best practices and new techniques in high-content, higher throughput investigations of excitation-contraction coupling in isolated cardiomyocytes.
Dr. Artur Fedorowski outlines the practical skills needed to perform a successful cardiovascular and autonomic workup in unexplained syncope and cardiovascular dysautonomia.
NMI experts describe quality control procedures and image corrections for the Bruker PET technology, demonstrate image transfer to PMOD for analysis and outline best practices to ensure good quantitative PET.